Cytokines released by Clostridium difficile "crucial" to prevent and manage prostate cancer

Written By :  Aditi
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-02-21 04:15 GMT   |   Update On 2023-02-21 07:31 GMT
Advertisement

An original article published in Cureus has concluded that there is a significant novel association between C. difficile and reduced incidence of Prostate Cancer (PC).

Clostridium difficile is a common hospital-acquired infection. It is associated with the release of various cytokines.

It is known that PC is the second most common cancer in men. C. difficile releases proinflammatory cytokines like interleukin (IL)-1β, IL-8, IL-16, and IL-17A, and regulatory and anti-inflammatory cytokines like IL-10, IL-23, and IL-48. The cytokines released may reduce PC development.

Advertisement

There is a possibility that anti-inflammatory and tumoricidal cytokines released by C.difficile infection decrease PC risk.

Considering this background, researchers investigated this relationship using PearlDiver national database. The patients with/without a history of infection were evaluated for PC incidence using the International Classification of Disease Ninth and Tenth Revision codes.

The study summary includes the following:

· 79,226 patients in infected and control groups were matched by age and CCI.

· 1827 patients in C. difficile group and 5565 in the control group had PC constituting 2.56 % and 7.79 %, respectively.

· Subsequent matching by antibiotic treatment resulted in two groups of 16,772 patients. PC incidence in the C.difficile group and control group was 1.62% and 3.95%.

To conclude, C. difficile infection reduces PC incidence. Further investigations are required to explore cytokines role released by C. difficile PC prevention and management.

Further reading:

Frankel L R et al. Clostridium difficile Infection Is Associated With Decreased Prostate Cancer Risk: A Retrospective Cohort Study. Cureus 15(1): e34398. doi:10.7759/cureus.34398

Tags:    
Article Source : Cureus

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News